Antitumor effects of novel shorter truncated insulin-like growth factor I receptors

References

• Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1997; 1332:F105 - 26; PMID: 9196021
   PubMed Web of Science ®Google Scholar
• Rubini M, Hongo A, D’Ambrosio C, Baserga R. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp Cell Res 1997; 230:284 - 92; http://dx.doi.org/10.1006/excr.1996.3430; PMID: 9024787
   PubMed Web of Science ®Google Scholar
• Werner H, Bruchim I. The insulin-like growth factor-I receptor as an oncogene. Arch Physiol Biochem 2009; 115:58 - 71; http://dx.doi.org/10.1080/13813450902783106; PMID: 19485702
   PubMedGoogle Scholar
• Kuramoto H, Hongo A, Liu YX, Ojima Y, Nakamura K, Seki N, et al. Immunohistochemical evaluation of insulin-like growth factor I receptor status in cervical cancer specimens. Acta Med Okayama 2008; 62:251 - 9; PMID: 18766208
   PubMed Web of Science ®Google Scholar
• Imsumran A, Adachi Y, Yamamoto H, Li R, Wang Y, Min Y, et al. Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma. Carcinogenesis 2007; 28:947 - 56; http://dx.doi.org/10.1093/carcin/bgl247; PMID: 17183068
   PubMed Web of Science ®Google Scholar
• Kalla Singh S, Tan QW, Brito C, De León M, De León D. Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women. Growth Horm IGF Res 2010; 20:245 - 54; http://dx.doi.org/10.1016/j.ghir.2010.03.001; PMID: 20347606
   PubMed Web of Science ®Google Scholar
• Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, et al. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 1997; 57:3079 - 83; PMID: 9242428
   PubMed Web of Science ®Google Scholar
• Kulik G, Klippel A, Weber MJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 1997; 17:1595 - 606; PMID: 9032287
   PubMed Web of Science ®Google Scholar
• Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, et al. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 1999; 19:7203 - 15; PMID: 10490655
   PubMed Web of Science ®Google Scholar
• Nakamura K, Hongo A, Kodama J, Miyagi Y, Yoshinouchi M, Kudo T. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines. Cancer Res 2000; 60:760 - 5; PMID: 10676665
   PubMed Web of Science ®Google Scholar
• Liu X, Turbyville T, Fritz A, Whitesell L. Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in mice. Cancer Res 1998; 58:5432 - 8; PMID: 9850076
   PubMed Web of Science ®Google Scholar
• Burfeind P, Chernicky CL, Rininsland F, Ilan J, Ilan J. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.. Proc Natl Acad Sci U S A 1996; 93:7263 - 8; http://dx.doi.org/10.1073/pnas.93.14.7263; PMID: 8692980
   PubMed Web of Science ®Google Scholar
• Trojan J, Johnson TR, Rudin SD, Ilan J, Tykocinski ML, Ilan J. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 1993; 259:94 - 7; http://dx.doi.org/10.1126/science.8418502; PMID: 8418502
   PubMed Web of Science ®Google Scholar
• Hongo A, Yumet G, Resnicoff M, Romano G, O’Connor R, Baserga R. Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor. Cancer Res 1998; 58:2477 - 84; PMID: 9622092
   PubMed Web of Science ®Google Scholar
• Liu Y, Lehar S, Corvi C, Payne G, O’Connor R. Expression of the IGF-I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells. Cancer Res 1988; 58:570 - 6
   Google Scholar
• Burgaud JL, Resnicoff M, Baserga R. Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem Biophys Res Commun 1995; 214:475 - 81; http://dx.doi.org/10.1006/bbrc.1995.2311; PMID: 7677754
   PubMed Web of Science ®Google Scholar
• D’Ambrosio C, Ferber A, Resnicoff M, Baserga R. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res 1996; 56:4013 - 20; PMID: 8752172
   PubMed Web of Science ®Google Scholar
• Prager D, Li HL, Asa S, Melmed S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci U S A 1994; 91:2181 - 5; http://dx.doi.org/10.1073/pnas.91.6.2181; PMID: 8134369
   PubMed Web of Science ®Google Scholar
• Dunn SE, Ehrlich M, Sharp NJ, Reiss K, Solomon G, Hawkins R, et al. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res 1998; 58:3353 - 61; PMID: 9699666
   PubMed Web of Science ®Google Scholar
• Hongo A, Kuramoto H, Nakamura Y, Hasegawa K, Nakamura K, Kodama J, et al. Antitumor effects of a soluble insulin-like growth factor I receptor in human ovarian cancer cells: advantage of recombinant protein administration in vivo. Cancer Res 2003; 63:7834 - 9; PMID: 14633710
   PubMed Web of Science ®Google Scholar
• Chitnis MM, Yuen JSP, Protheroe AS, Pollak M, Macaulay VM. The type 1 insulin-like growth factor receptor pathway. Clin Cancer Res 2008; 14:6364 - 70; http://dx.doi.org/10.1158/1078-0432.CCR-07-4879; PMID: 18927274
   PubMed Web of Science ®Google Scholar
• Atzori F, Traina TA, Ionta MT, Massidda B. Targeting insulin-like growth factor type 1 receptor in cancer therapy. Target Oncol 2009; 4:255 - 66; http://dx.doi.org/10.1007/s11523-009-0123-z; PMID: 19876700
   PubMed Web of Science ®Google Scholar
• Katakura Y, Seto P, Miura T, Ohashi H, Teruya K, Shirahata S. Productivity enhancement of recombinant protein in CHO cells via specific promoter activation by oncogenes. Cytotechnology 1999; 31:103 - 9; http://dx.doi.org/10.1023/A:1008048928053; PMID: 19003130
   PubMed Web of Science ®Google Scholar
• Nakamura S, Watanabe H, Miura M, Sasaki T. Effect of the insulin-like growth factor I receptor on ionizing radiation-induced cell death in mouse embryo fibroblasts. Exp Cell Res 1997; 235:287 - 94; http://dx.doi.org/10.1006/excr.1997.3683; PMID: 9281378
   PubMed Web of Science ®Google Scholar
• Sell C, Baserga R, Rubin R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res 1995; 55:303 - 6; PMID: 7812962
   PubMed Web of Science ®Google Scholar
• Dunn SE, Hardman RA, Kari FW, Barrett JC. Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res 1997; 57:2687 - 93; PMID: 9205078
   PubMed Web of Science ®Google Scholar
• Prisco M, Hongo A, Rizzo MG, Sacchi A, Baserga R. The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol Cell Biol 1997; 17:1084 - 92; PMID: 9032235
   PubMed Web of Science ®Google Scholar
• D’Ambrosio C, Valentinis B, Prisco M, Reiss K, Rubini M, Baserga R. Protective effect of the insulin-like growth factor I receptor on apoptosis induced by okadaic acid. Cancer Res 1997; 57:3264 - 71; PMID: 9242459
   PubMed Web of Science ®Google Scholar
• Werner H, Le Roith D. New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia. Cell Mol Life Sci 2000; 57:932 - 42; http://dx.doi.org/10.1007/PL00000735; PMID: 10950308
   PubMed Web of Science ®Google Scholar
• Larsson O, Girnita A, Girnita L. Role of insulin-like growth factor 1 receptor signalling in cancer. Br J Cancer 2005; 92:2097 - 101; http://dx.doi.org/10.1038/sj.bjc.6602627; PMID: 15956962
   PubMed Web of Science ®Google Scholar
• Reiss K, D’Ambrosio C, Tu X, Tu C, Baserga R. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect. Clin Cancer Res 1998; 4:2647 - 55; PMID: 9829727
   PubMed Web of Science ®Google Scholar
• O’Connor R, Kauffmann-Zeh A, Liu Y, Lehar S, Evan GI, Baserga R, et al. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol 1997; 17:427 - 35; PMID: 8972223
   PubMed Web of Science ®Google Scholar
• Reiss K, Yumet G, Shan S, Huang Z, Alnemri E, Srinivasula SM, et al. Synthetic peptide sequence from the C-terminus of the insulin-like growth factor-I receptor that induces apoptosis and inhibition of tumor growth. J Cell Physiol 1999; 181:124 - 35; http://dx.doi.org/10.1002/(SICI)1097-4652(199910)181:1<124::AID-JCP13>3.0.CO;2-0; PMID: 10457360
   PubMed Web of Science ®Google Scholar
• Reiss K, Tu X, Romano G, Peruzzi F, Wang JY, Baserga R. Intracellular association of a mutant insulin-like growth factor receptor with endogenous receptors. Clin Cancer Res 2001; 7:2134 - 44; PMID: 11448933
   PubMed Web of Science ®Google Scholar
• Hongo A, D’Ambrosio C, Miura M, Morrione A, Baserga R. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene 1996; 12:1231 - 8; PMID: 8649825
   PubMed Web of Science ®Google Scholar